Quercetin, as a natural molecular product, possesses a significant therapeutical effect on osteoporosis and fewer adverse reactions, which makes it an ideal drug candidate for rebalancing bone metabolism and treating osteoporosis, especially for the postmenopausal osteoporosis patients with a low serum MALAT1 level. The gene discussed is MALAT1; the disease is osteoporosis.